309
Views
0
CrossRef citations to date
0
Altmetric
Rapid Communications

An in silico study on pulmonary fibrosis inhibitors from Tinospora cordifolia and Curcuma longa targeting TGF-β RI

, ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon
Pages 3145-3161 | Received 19 May 2021, Accepted 11 Jan 2022, Published online: 24 Jan 2022
 

Abstract

Pulmonary fibrosis is characterized by damage to the epithelial cells and alveolar-capillary basement membrane. The increased expression levels of transforming growth factor β (TGF-β) and TGF-β-receptor-1 induced differentiation of lung fibroblasts to myofibroblasts, an alarming sign and considered the hallmark event development of pulmonary fibrosis. In the current study, the stability of phytochemicals of Curcuma longa and Tinospora cordifolia as inhibitors of transforming growth factor β RI (TGF-β RI) were evaluated using molecular docking and molecular dynamics studies. A total of 108 Curcuma longa and 16 Tinospora cordifolia constituents were screened against TGF-β RI as the target. Further, their ADMET properties were evaluated using the pkCSM online server. The compounds tembetarine, magnoflorine from T. cordiolia, and 2-(Hydroxymethyl) anthraquinone and quercetin in C. longa showed significant binding affinities bonding interactions with the target, TGF-β RI, and the study was compared with the known inhibitors from the literature. The MD simulations study also supported that the selected compounds show a close affinity with the binding site and maintained stable behavior throughout the simulation time. The pharmacophore feature analysis of the selected compounds and inhibitors were analyzed using the pharmagist web server, and the common features like H-bond donor and aromatic ring were mapped.

Communicated by Ramaswamy H. Sarma

Acknowledgment

The authors acknowledge the facilities supported by the Department of Science and Technology, the Government of India (FIST Project No: LSI-576/2013), and the Centre of Excellence, Department of Biotechnology, Vignan’s Foundation for Science, Technology and Research.

Disclosure statement

No potential conflict of interest was reported by the authors.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.